Taurolidine-containing solution for reducing cardiac implantable electronic device infection-early report from the European TauroPace™ registry
Abstract Introduction Infection is a significant complication of cardiac implantable electronic device (CIED) therapy. The European TauroPace™ Registry investigates the safety and efficacy of TauroPace™ (TP), an antimicrobial solution containing taurolidine, designed to prevent CIED infections. Meth...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2024-10-01
|
| Серія: | Journal of Cardiothoracic Surgery |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s13019-024-03059-1 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
